Publication | Closed Access

Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats

InflammationT2dm/nafld RatsLiver LesionsMedicineLiver PhysiologyAdult Stem CellImmunologyStem-cell TherapyCell BiologyMesenchymal Stem CellStem CellsCell TransplantationDrug-induced Liver InjuryOxidative StressHealth Sciences